A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought.

A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than ...

Researchers at UCLA have unveiled startling findings using PSMA-PET imaging that reveal nearly half of patients diagnosed ...

Prostate cancer is a health issue that impacts individuals worldwide, and choosing the best treatment can be difficult, given ...

Researchers at UC San Diego have discovered that the enzyme MICAL2 accelerates tumor growth in pancreatic cancer by ...

Hundreds of Australians with breast and prostate cancer will benefit from new treatments being added to the Pharmaceutical ...

This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description: ...

Almost three in five cancers - including breast, prostate and lung - are being found at stages one or two, when treatment is ...

After a tough 2024, 2025 will likely see the three kids “be up for a few treats this year,” according to Ingrid Seward ...

The study found that Focal One's treatment methods match up with the gold star standard of surgery, and improve quality of life outcomes.

During an in-person Community Case Forum event in Miami, Florida, Mike Cusnir, MD, discussed the ARANOTE study outcomes ...

EXCLUSIVE - Cruel bladder cancer may have found a determined new adversary after an experimental drug have proven to not only ...